1,720
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Effectiveness of varicella vaccine as post-exposure prophylaxis: a meta-analysis

, &
Pages 5316-5324 | Received 04 Aug 2021, Accepted 19 Nov 2021, Published online: 10 Dec 2021

References

  • Heininger U, Seward JF. Varicella. Lancet (London, England). 2006;368:1365–76. doi:10.1016/s0140-6736(06)69561-5.
  • Bozzola E, Bozzola M. Varicella complications and universal immunization. J Pediatr (Rio J). 2016;92:328–30. doi:10.1016/j.jped.2016.05.001.
  • Twh O. Varicella and herpes zoster vaccines: WHO position paper, June 2014. Releve Epidemiologique Hebd. 2014;89:265–87.
  • Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet (London, England). 1974;2:1288–90. doi:10.1016/s0140-6736(74)90144-5.
  • Wutzler P, Bonanni P, Burgess M, Gershon A, Sáfadi MA, Casabona G. Varicella vaccination - the global experience. Expert Rev Vaccines. 2017;16:833–43. doi:10.1080/14760584.2017.1343669.
  • Grose C. Varicella vaccination of children in the United States: assessment after the first decade 1995-2005. J Clin Virol. 2005;33:89–95;discussion 6–8. doi:10.1016/j.jcv.2005.02.003.
  • Prevention of varicella. Update recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations Rep. 1999;48:1–5.
  • Marin M, Güris D, Chaves SS, Schmid S, Seward JF. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations Rep. 2007;56:1–40.
  • Asano Y, Nakayama H, Yazaki T, Kato R, Hirose S. Protection against varicella in family contacts by immediate inoculation with live varicella vaccine. Pediatrics. 1977;59:3–7.
  • Asano Y, Hirose S, Iwayama S, Miyata T, Yazaki T, Takahashi M. Protective effect of immediate inoculation of a live varicella vaccine in household contacts in relation to the viral dose and interval between exposure and vaccination. Biken J. 1982;25:43–45.
  • Naganuma Y, Osawa S, Takahashi R. Clinical application of a live varicella vaccine (Oka strain) in a hospital. Biken J. 1984;27:59–61.
  • Arbeter AM, Starr SE, Plotkin SA. Varicella vaccine studies in healthy children and adults. Pediatrics. 1986;78:748–56.
  • Cao Z, Chen D, Yang Y, Zhang D. Effectiveness of post-exposure prophylaxis during varicella outbreaks among primary and middle school students in Shanghai: an analysis of three-year surveillance data. Vaccine. 2018;36:5754–59. doi:10.1016/j.vaccine.2018.08.004.
  • Yang Y. Effectiveness of vaccination following varicella outbreaks among schools in Hongkou district, Shanghai. Zhonghua Yu Fang Yi Xue Za Zhi [Chin J Preventive Med]. 2016;50:91–93. doi:10.3760/cma.j.0253-9624.2016.01.016.
  • Wu Q, Liu J, Wang Y, Zhou Q, Wang X, Xuan Z, Zhang L, Gao Y, Chen B, Hu Y, et al. Effectiveness of second-dose varicella vaccination as post-exposure prophylaxis: a prospective cohort study. Clin Microbiol Infect. 2019;25:872–77. doi:10.1016/j.cmi.2018.11.013.
  • Mor M, Harel L, Kahan E, Amir J. Efficacy of postexposure immunization with live attenuated varicella vaccine in the household setting–a pilot study. Vaccine. 2004;23:325–28. doi:10.1016/j.vaccine.2004.06.004.
  • Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (Clinical Research Ed). 2009;339:b2535. doi:10.1136/bmj.b2535.
  • Stang A. Critical evaluation of the Newcastle-Ottawa scale for the as sessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–605.
  • Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clinical Research Ed). 2003;327:557–60. doi:10.1136/bmj.327.7414.557.
  • DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88. doi:10.1016/0197-2456(86)90046-2.
  • Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.
  • Greenwood M, Yule GU. The statistics of anti-typhoid and anti-cholera inoculations, and the interpretation of such statistics in general. Proc R Soc Med. 1915;8:113–94. doi:10.1177/003591571500801433.
  • Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Research Ed). 1997;315:629–34. doi:10.1136/bmj.315.7109.629.
  • Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101. doi:10.2307/2533446.
  • Watson B, Seward J, Yang A, Witte P, Lutz J, Chan C, Orlin S, Levenson R. Postexposure effectiveness of varicella vaccine. Pediatrics. 2000;105:84–88. doi:10.1542/peds.105.1.84.
  • Pinochet C, Cerda J, Hirsch T, Mieres J, Inostroza C, Abarca K. Effectiveness of varicella vaccine as post exposure prophylaxis in Chilean children. Revista Chilena de Infectologia: Organo Oficial de La Sociedad Chilena de Infectologia. 2012;29:635–40. doi:10.4067/s0716-10182012000700008.
  • Fu JY, Dun Z, Sun PY, Xu RH, Dong SL. Evaluation of emergency immunization effect of an varicella outbreak in a primary school. Chin J Nat Med. 2008;10:448–49.
  • Ma R, Sun MP, Sun M, Hou WJ, Jiang GY, Peng XH, Wu J. Effectiveness on post-exposure vaccination of varicella and its influencing factors in elementary schools in Beijing. Chin J Epidemiol. 2009;30:559–63.
  • Yang Y. Effectiveness of vaccination following varicella outbreaks among schools in Hongkou district Shanghai. Chin J Prev Med. 2016;50:91–93.
  • Wu QS, Liu M, Wu AQ, Zhou Q, Shen H, Zhang JJ, Liu JY. The vaccine protection effect of a public health emergency caused by varicella in a junior high school in Shanghai. J Prev Med Inf. 2016;32:289–93.
  • Nguyen MD, Perella D, Watson B, Marin M, Renwick M, Spain CV. Incremental effectiveness of second dose varicella vaccination for outbreak control at an elementary school in Philadelphia, Pennsylvania, 2006. Pediatr Infect Dis J. 2010;29:685–89. doi:10.1097/INF.0b013e3181d9f657.
  • Wu QS, Liu JY, Wang X, Chen YF, Zhou Q, Wu AQ, Wang L. Effectiveness of varicella vaccine as post-exposure prophylaxis during a varicella outbreak in Shanghai, China. Int J Infect Dis. 2018;66:51–55. doi:10.1016/j.ijid.2017.10.016.
  • Wu QS, Wang X, Liu JY, Chen YF, Zhou Q, Wang Y, Sha J-D, Xuan Z-L, Zhang L-W, Yan L, et al. Varicella outbreak trends in school settings during the voluntary single-dose vaccine era from 2006 to 2017 in Shanghai, China. Int J Infect Dis. 2019;89:72–78. doi:10.1016/j.ijid.2019.09.009.
  • McDonald J. Vaccines for postexposure prophylaxis against varicella (chickenpox) in children and adults. Paediatr Child Health. 2016;21:91–92. doi:10.1093/pch/21.2.91.
  • Belongia EA, Simpson MD, King JP, Sundaram ME, Kelley NS, Osterholm MT, McLean HQ. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis. 2016;16:942–51. doi:10.1016/s1473-3099(16)00129-8.
  • Seward JF, Zhang JX, Maupin TJ, Mascola L, Jumaan AO. Contagiousness of varicella in vaccinated cases: a household contact study. Jama. 2004;292:704–08. doi:10.1001/jama.292.6.704.
  • Ceyhan M, Tezer H, Yildirim I. Secondary attack rate of hepatitis A, varicella and mumps in household settings and reliability of family history to detect seronegative children for necessity of vaccination. Scand J Infect Dis. 2009;41:501–06. doi:10.1080/00365540902968027.
  • Poulsen A, Cabral F, Nielsen J, Roth A, Lisse IM, Vestergaard BF, Aaby P. Varicella zoster in Guinea-Bissau: intensity of exposure and severity of infection. Pediatr Infect Dis J. 2005;24:102–07. doi:10.1097/01.inf.0000151034.15747.4a.
  • Watson B, Rothstein E, Bernstein H, Arbeter A, Arvin A, Chartrand S, Clements D, Kumar ML, Reisinger K, Blatter M, et al. Safety and cellular and humoral immune responses of a booster dose of varicella vaccine 6 years after primary immunization. J Infect Dis. 1995;172:217–19. doi:10.1093/infdis/172.1.217.
  • Zhang X, Yan Y, Liu F, Luo Y, Zhang J, Peng X, Zhang Y, Han S, Zhao J, He Y. The epidemiology and risk factors for breakthrough varicella in Beijing Fengtai district. Vaccine. 2012;30:6186–89. doi:10.1016/j.vaccine.2012.07.062.
  • Yin M, Xu X, Liang Y, Ni J. Effectiveness, immunogenicity and safety of one vs. two-dose varicella vaccination: ameta-analysis. Expert Rev Vaccines. 2018;17:351–62. doi:10.1080/14760584.2018.1433999.
  • Sharrar RG, LaRussa P, Galea SA, Steinberg SP, Sweet AR, Keatley RM, Wells ME, Stephenson WP, Gershon AA. The postmarketing safety profile of varicella vaccine. Vaccine. 2000;19:916–23. doi:10.1016/s0264-410x(00)00297-8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.